Veopoz (pozelimab-bbfg)
VEOPOZ is used to treat adults and children 1 year of age and older with a disease called CD55-deficient protein-losing enteropathy (PLE), also known as CHAPLE disease. It is not known if VEOPOZ is safe and effective in children younger than 1 year of age.
| Brand Name: | Veopoz |
| Generic Name: | pozelimab-bbfg |
| Strength: | |
| Manufacturer: | |
| Approved By: | EMA, USFDA |
Source Details: Patient Information
IPN, New Delhi can facilitate patient to import of “Veopoz (pozelimab-bbfg)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for Veopoz (pozelimab-bbfg) price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.
